Colon targeted drug delivery systems: a review on primary and novel approaches AK Philip, B Philip Oman medical journal 25 (2), 79, 2010 | 572 | 2010 |
Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, AK Philip Journal of the American College of Cardiology, 2350-2473, 2023 | 401 | 2023 |
Modified transdermal technologies: Breaking the barriers of drug permeation via the skin R Kumar, A Philip Tropical journal of pharmaceutical research 6 (1), 633-644, 2007 | 343 | 2007 |
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … GBD Collborators, Philip A.K The Lancet, 2024 | 332 | 2024 |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … Anil K. Philip, GBD Collaborators The Lancet, 2024 | 332 | 2024 |
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, Aravkin, GBD Collborators, Anil K. Philip The Lancet 403 (10440), 2162-2203, 2024 | 313 | 2024 |
Drug delivery: principles and applications B Wang, L Hu, TJ Siahaan John Wiley & Sons, 2016 | 282 | 2016 |
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, Abate, GBD Collaborators, Anil K Philip The Lancet 403 (10440), 2204-2256, 2024 | 132 | 2024 |
Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility AK Philip, K Pathak Aaps Pharmscitech 7, E1-E11, 2006 | 105 | 2006 |
Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis AK Philip, S Dabas, K Pathak Journal of drug targeting 17 (3), 235-241, 2009 | 86 | 2009 |
Dendrimers: Nanotechnology derived novel polymers in drug delivery S Pushkar, A Philip, K Pathak, D Pathak Indian Journal of Pharmaceutical Education and Research 40 (3), 153, 2006 | 85 | 2006 |
Gastroretentive dosage forms for prolonging gastric residence time R Kumar, A Philip International Journal of Pharmaceutical Medicine 21, 157-171, 2007 | 79 | 2007 |
Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin J Singh, AK Philip, K Pathak Aaps Pharmscitech 9, 60-66, 2008 | 77 | 2008 |
Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil AK Philip, K Pathak, P Shakya European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 658-666, 2008 | 71 | 2008 |
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, GBD Collborators, Philip A.K. The Lancet, 2024 | 69 | 2024 |
Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug AK Philip, K Pathak Drug development and industrial pharmacy 34 (7), 735-743, 2008 | 57 | 2008 |
Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach AK Philip, RK Dubey, K Pathak Journal of Pharmacy and Pharmacology 60 (5), 607-613, 2008 | 56 | 2008 |
Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin V Sharma, AK Philip, K Pathak Aaps Pharmscitech 9, 87-94, 2008 | 55 | 2008 |
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 Wu, Dongze et, AK Philip EClinicalMedicine 64, 2023 | 44 | 2023 |
In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug A Philip, K Pathak PDA Journal of Pharmaceutical Science and Technology 61 (1), 24-36, 2007 | 44 | 2007 |